Astellas Pharma, Inc. (ALPMY)
15.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Astellas Pharma Net Income (Quarterly) : 889.54M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 889.54M |
| March 31, 2026 | 278.00M |
| December 31, 2025 | 651.15M |
| September 30, 2025 | 537.30M |
| June 30, 2025 | 473.28M |
| March 31, 2025 | 491.43M |
| December 31, 2024 | -640.89M |
| September 30, 2024 | 240.61M |
| June 30, 2024 | 241.31M |
| March 31, 2024 | -224.13M |
| December 31, 2023 | 98.13M |
| September 30, 2023 | -10.09M |
| June 30, 2023 | 240.88M |
| March 31, 2023 | -348.39M |
| December 31, 2022 | 342.29M |
| September 30, 2022 | 517.77M |
| June 30, 2022 | 191.10M |
| March 31, 2022 | -72.30M |
| December 31, 2021 | 535.37M |
| September 30, 2021 | 371.73M |
| June 30, 2021 | 280.51M |
| March 31, 2021 | -116.19M |
| December 31, 2020 | 575.00M |
| September 30, 2020 | 211.28M |
| June 30, 2020 | 468.85M |
| Date | Value |
|---|---|
| March 31, 2020 | 49.46M |
| December 31, 2019 | 565.67M |
| September 30, 2019 | 652.23M |
| June 30, 2019 | 532.36M |
| March 31, 2019 | 278.99M |
| December 31, 2018 | 777.40M |
| September 30, 2018 | 442.32M |
| June 30, 2018 | 499.81M |
| March 31, 2018 | 203.74M |
| December 31, 2017 | 535.89M |
| September 30, 2017 | 357.32M |
| June 30, 2017 | 382.12M |
| March 31, 2017 | 351.36M |
| December 31, 2016 | 582.02M |
| September 30, 2016 | 473.36M |
| June 30, 2016 | 617.28M |
| March 31, 2016 | 253.02M |
| December 31, 2015 | 507.70M |
| September 30, 2015 | 479.32M |
| June 30, 2015 | 365.90M |
| March 31, 2015 | 177.16M |
| December 31, 2014 | 383.15M |
| September 30, 2014 | 323.83M |
| June 30, 2014 | 352.51M |
| December 31, 2013 | 327.03M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 430.72M |
| Takeda Pharmaceutical Co., Ltd. | 710.72M |
| Ono Pharmaceutical Co., Ltd. | 151.63M |
| Eisai Co., Ltd. | 120.18M |
| Chugai Pharmaceutical Co., Ltd. | 730.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.022B |
| Total Expenses (Quarterly) | 3.133B |
| EPS Diluted (Quarterly) | 0.4955 |
| Enterprise Value | 29.10B |
| Gross Profit Margin (Quarterly) | 75.29% |
| Profit Margin (Quarterly) | 22.12% |
| Earnings Yield | 8.72% |
| Operating Earnings Yield | 11.84% |
| Normalized Earnings Yield | 8.717 |